" /> Tuvonralimab - CISMeF





Preferred Label : Tuvonralimab;

NCIt definition : An immunoglobulin G1 (IgG1) monoclonal antibody directed against the human T-cell receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), with immune checkpoint inhibitory and antineoplastic activities. Upon administration, tuvonralimab binds to CTLA-4 expressed on T-cells and inhibits the CTLA-4-mediated downregulation of T-cell activation. This leads to a cytotoxic T-lymphocyte (CTL)-mediated immune response against cancer cells. CTLA-4, an inhibitory receptor and member of the immunoglobulin superfamily, plays a key role in the downregulation of the immune system.;

UNII : 8XWO7LI4LO;

CAS number : 2417649-44-4;

Molecule name : PBS-105;

NCI Metathesaurus CUI : CL1905426;

Details


You can consult :


Nous contacter.
02/06/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.